How Healthtech Founders Win Grant Funding in 2026
UK and EU Healthtech funding is shifting quickly – and many founders are applying with the wrong strategy.
In this practical 60-minute session, you’ll learn how to align your clinical, regulatory, and funding plans so you can access the right grants at the right time – without slowing down your raise.
Led by Cheryl Eggleston (Founder, Pitchwits), who has supported over £200m in funding secured across grants and private capital.
What we will cover
How clinical and regulatory pathways intersect with grant funding strategy – and why aligning them early changes what you can access
The role of philanthropic and charity funding in your Healthtech journey, including routes through the Wellcome Trust, British Heart Foundation, and similar bodies
Updates on the UK and EU's Healthtech funding priorities for 2026 – including Frontier AI for life sciences and biotech missions, Innovate UK's Biomedical Catalyst, the NIHR i4i grant suite, and opportunities through Horizon Europe and international collaborations
How to think about your funding mix across grants, philanthropy, and private capital as you build – and common strategic mistakes that cost founders time and momentum
Who should attend
Healthtech founders (pre-seed to Series A)
R&D or clinical leads planning trials or validation
Teams exploring non-dilutive funding alongside a raise
Meet our speaker
Cheryl is the Founder of Pitchwits, a UK-based AI-enabled innovation funding startup that combines specialist grant and investment consultancy with a suite of intelligent AI agents. Across her career she has overseen almost £200m in funding secured by innovators through grants and private capital – spanning grant strategy, private investment research, and the practical realities of helping founders get funded.
Please note
By registering for this event, you consent for your details to be shared with all event partners, as listed.